Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling

por Ibrahim, Sherif A., Hassan, Hebatallah, Vilardo, Laura, Kumar, Sampath Katakam, Kumar, Archana Vijaya, Kelsch, Reinhard, Schneider, Cornelia, Kiesel, Ludwig, Eich, Hans Theodor, Zucchi, Ileana, Reinbold, Rolland, Greve, Burkhard, Götte, Martin
Publicado 2013